Sunday, December 3, 2023

PUMA RE:SUEDE Pilot Project Turns Experimental Sneakers Into Compost

 HERZOGENAURACH, Germany - Wednesday, 29. November 2023

(BUSINESS WIRE)--Sports company PUMA showed that it can successfully turn an experimental version of its classic SUEDE sneaker into compost under certain tailor-made industrial conditions, as it announced the results of its two-year-long RE:SUEDE experiment.

In 2021, PUMA created 500 pairs of the experimental RE:SUEDE, using Zeology tanned suede, a TPE outsole and hemp fibres. The RE:SUEDEs were worn for half a year by volunteers in Germany to test the comfort and durability of the shoes before PUMA sent them to a specially equipped industrial composting area operated by its partner Ortessa Group in the Netherlands.

A special procedure had to be established to turn the shoes into compost. First, they were shredded and mixed with other green household waste and placed into a composting tunnel. They were then sprayed with leaching-water from earlier composting that contains nutrients and naturally heated due to the biological activity and controlled air circulation in the tunnel. After approximately 3.5 months, the materials that were small enough (<10mm) to pass through a sieve were sold as Grade A compost for agricultural use (within the standards of the Netherlands), while the remaining materials were returned to the composting tunnel until they too had broken down to the desired level (<10mm). Ortessa Group adhered to all legal requirements for compost applicable at their facilities in the Netherlands during this process.

“While the RE:SUEDE could not be processed under the standard operating procedures for industrial composting, the shoes did eventually turn into compost,” said Anne-Laure Descours, Chief Sourcing Officer at PUMA. “We will continue to innovate with our partners to determine the infrastructure and technologies needed to make the process viable for a commercial version of the RE:SUEDE, including a takeback scheme, in 2024.”

Transparency is another important pillar of the RE:SUEDE experiment, as PUMA will share its insights in a detailed report, so its peers and other interested stakeholders can learn from the experiment and apply the learnings to their own initiatives.

“We learned a lot during the RE:SUEDE trial and how to streamline our industrial composting process to include items that need longer to turn into compost,” said Marthien van Eersel Manager Materials & Innovations at Ortessa. “While all RE:SUEDE materials can decompose, the sole of the RE:SUEDE required more pre-processing and additional time in the composting tunnel to completely break down.”

As a result of the feedback received from the people who wore the RE:SUEDE for half a year, PUMA will improve the comfort of future versions of the shoes by enhancing the overall fit by using a new material pattern for the upper and the sock liner.

The RE:SUEDE experiment was the first programme, together with the novel polyester recycling programme RE:FIBRE, to launch as part of PUMA’s “Circular Lab”, an innovation hub led by PUMA’s innovation and design experts with the aim to create the future of the company’s circularity programmes.

For more information, please visit and


PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

Ortessa Group

Ortessa is a group of five enterprising waste companies: veyzle,, van Kaathoven, Rondo and Valor Composting. Together, the subsidiaries master all links of waste management, collection and processing and prove daily the power of smart partnering. Each with its own specialism in the field of waste, but with one clear joint mission: to be open about waste. With a realistic, pragmatic and results-oriented view, the Ortessa Group helps clients deal with waste challenges.


View source version on



Samantha Du Plessis – PUMA SE –

M. Schepers – Ortessa –

Friday, December 1, 2023

Results From Galderma’s Phase IIIb Trials Demonstrate Rapid and Long-Lasting Effect of RelabotulinumtoxinA on Crow’s Feet and Frown Lines

 ZUG, Switzerland - Thursday, 30. November 2023

Both trials met their primary endpoints, demonstrating treatment with RelabotulinumtoxinA resulted in a statistically significant improvement in frown lines and crow’s feet.1,2

Results reinforce the rapid onset of action of RelabotulinumtoxinA, with some patients reporting improvement as early as day one in both trials.1,2

Results also underscore the durability of RelabotulinumtoxinA with at least a third of patients rating their frown lines as ‘improved’ or better through to month 12 in one study.2

Treatment was well tolerated and all treatment-related adverse events were reported as non-serious.1,2


(BUSINESS WIRE) -- Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines (GL – frown lines) and lateral canthal lines (LCL – crow’s feet). Both studies met their primary endpoints, demonstrating that RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, significantly improves both frown lines and crow’s feet, with a rapid onset of action as early as day one and long duration.1,2


“These results provide an additional layer of confidence in the long-lasting efficacy, speed and convenience of RelabotulinumtoxinA, which not only represents the innovation of our neuromodulator portfolio, but also demonstrates our commitment to responding to the real needs of healthcare professionals and patients.”







43QM2106 is a phase IIIb, randomized, double-blind, placebo-controlled trial to assess the aesthetic improvement and onset of action of RelabotulinumtoxinA in patients with moderate to severe frown lines. The trial met its primary endpoint, with 92.9% of those treated with RelabotulinumtoxinA rating their frown lines as ‘improved’ or better on the Global Aesthetic Improvement Scale (GAIS) at month one, compared to 9.1% of those treated with placebo (P<0.001).1

Results reinforced the rapid onset of action and durability of RelabotulinumtoxinA, with 40% of patients rating themselves as ‘improved’ or better on the GAIS as early as day one, and more than a third (38%) of patients rating themselves as ‘improved’ or better at month 12. In addition, 68% and 43% of patients rated themselves as ‘improved’ or better at months six and nine respectively, and 40% of patients also reported at least a one grade improvement of frown line severity at month nine. RelabotulinumtoxinA was well tolerated; the majority of patients did not experience any adverse events and there were no related serious adverse events reported.1

43QM2107 is a phase IIIb, open-label, single-center study to assess aesthetic improvement of RelabotulinumtoxinA in patients with moderate to severe crow’s feet and frown lines. It also met its primary endpoint, with 100% of patients treated with RelabotulinumtoxinA rating their crow’s feet and frown lines as ‘improved’ or better on the GAIS at month one.2

RelabotulinumtoxinA demonstrated a rapid onset of action for both crow’s feet and frown lines, with the majority of patients (68% and 60% for crow’s feet and frown lines, respectively) rating themselves as ‘improved’ or better on the GAIS starting at day one. By day two, 100% of patients noted improvement for crow’s feet and 96% noted improvement for frown lines. This was reinforced by Subject Live Assessment results using a validated scale, which showed that 40% of patients on day one and 96% of patients on day four received a score of zero or one on a four-point scale for crow’s feet severity at maximum expression. For frown line severity, 32% of patients on day one and 92% of patients on day four received a score of zero or one. RelabotulinumtoxinA was well tolerated, with no adverse events reported in 92% of patients.2

Results from both studies are in line with those previously seen for RelabotulinumtoxinA.3,4

About RelabotulinumtoxinA (QM1114) 

Developed by Galderma, RelabotulinumtoxinA is a highly-active, innovative, complex-free, and ready-to-use liquid botulinum toxin A with a proprietary strain and manufactured using a unique state-of-the-art process. It is designed as a liquid, avoiding the traditional requirement to reconstitute from powder and eliminating variability, errors and risks associated with reconstitution, which would be expected to improve the consistency of results. RelabotulinumtoxinA is currently being investigated globally by Galderma to expand its neuromodulator portfolio as part of the broadest Injectable Aesthetics portfolio on the market.

About Galderma 

Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market though Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information:


Galderma data on file: initial results of the phase IIIb 43QM2106 trial

Galderma data on file: initial results of the phase IIIb 43QM2107 trial

Shridharani, S., et al. Treatment of moderate-to-severe glabellar lines with RelabotulinumtoxinA, a new liquid botulinum toxin: Clinical efficacy and safety results from the READY-1 Phase III trial. Poster presented at Vegas Cosmetic Surgery & Aesthetic Dermatology 2022, Las Vegas, NV, June 8-11, 2022

Ibrahim, SF, et al. Treatment of lateral canthal lines with RelabotulinumtoxinA, a new liquid botulinum toxin: Clinical efficacy and safety results from the READY-2 Phase III trial. Poster presented at Vegas Cosmetic Surgery & Aesthetic Dermatology 2022, Las Vegas, NV, June 8-11, 2022.


View source version on



Christian Marcoux, M.Sc.

Chief Communications Officer

+41 76 315 26 50

S├ębastien Cros

Corporate Communications Director

+41 79 529 59 85

Emil Ivanov

Head of Strategy, Investor Relations, and ESG

+41 21 642 78 12

Jessica Cohen

Investor Relations and Strategy Director

+41 21 642 76 43


Adani Power to Co-fire Green Ammonia at its Mundra Plant for a Sustainable Future

AHMEDABAD, India - Wednesday, 29. November 2023
  • Green Ammonia, whose combustion produces no CO2 emission, to co-fire a 330MW Unit
  • APL is working with Japan’s IHI Corporation & KOWA for the pilot
  • The project is under the aegis of Japan-India Clean Energy Partnership

(BUSINESS WIRE)--As the world leaders converge in the UAE for the UN Climate Change Conference (COP 28) from 30 November to 12 December 2023 to fast-track energy transition and slash emissions before 2030, Adani Power Ltd., India’s largest private sector power generator, has undertaken a ground-breaking green ammonia combustion pilot project at its Mundra plant as part of its multipronged decarbonization initiatives.

As part of the project, the Mundra Plant, which is India’s largest private sector power plant, will co-fire up to 20% green ammonia in the boiler of a conventional coal fired 330MW Unit.

Green ammonia, produced from green hydrogen, which in turn is produced through electrolysis using renewable energy, would be a feedstock for the boilers. As ammonia contains no carbon, there is no CO2 emission from its combustion, making it a long-term carbon neutral alternative to fossil fuels. Adani Power has already set a benchmark in the industry for ‘per-unit’ emissions and has adopted state of the art ‘Ultra Supercritical technology’ in its newest plants.

Adani Power has partnered with Japan’s IHI and Kowa to deliver the pilot and examine expansion to other APL units and stations. Kowa is active in energy saving and energy creating products, while IHI is a heavy industry company which has ammonia firing technology.

Combustion tests at IHI’s facility in Japan have begun with 20% ammonia blend, simulating Mundra Power Station equipment. The partners believe that the results will be encouraging enough to implement this solution at the Mundra Power Station once economic parity is achieved between both feedstocks. The Mundra plant is the first location outside of Japan to have been selected for this cutting-edge green initiative.

The project has been conceived under the aegis of Japan-India Clean Energy Partnership (CEP), which aims to ensure energy security, achieve carbon neutrality, and achieve economic growth. It has been selected under the New Energy and Industrial Technology Development Organization’s (NEDO) "International Demonstration Project for Japanese Technologies Contributing to Decarbonization and Energy Transition". NEDO is Japan’s national research and development agency that fosters innovation by promoting technological development necessary for realization of a sustainable society.

“Adani Power is fully committed to reducing its carbon footprint through adoption of latest technologies and proactive measures across our business value chain. In furtherance of this vision, we are happy to partner with IHI and Kowa for blending green ammonia for our Mundra plant, which will reduce CO2 emissions. We will continue to integrate cutting-edge technologies increasingly to reduce emissions in the intermediate term,” said Mr. Anil Sardana, Managing Director, Adani Power Ltd.

For more information, visit


View source version on



For media queries, contact Roy Paul:

Aviz Networks Expands Funding to $10M With New Investments From Accton, Cisco Investments and Wistron

 SAN JOSE, Calif. 

Funding to accelerate customer momentum for Aviz’s multi-vendor, GenAI-based networking stack along with adoption of SONiC based open networking

(BUSINESS WIRE)--Aviz Networks, a leader in open networking software for cloud-scale infrastructures serving telecom and enterprises, today announced it has added Cisco Investments to its latest funding expansion, joining existing investors, Moment Ventures, Accton and Wistron. This funding round, now reaching $10M, will accelerate customer momentum for Aviz’s multi-vendor, GenAI-based networking stack along with adoption of SONiC based open networking.

Aviz helps organizations achieve the performance and cost benefits of hyperscale networks by removing complexity and supplying AI-driven management features as part of a breakthrough Networking 3.0 software stack. Aviz’s stack supports the fast-growing SONiC open-source network OS (NOS) as well as multi-NOS environments and leverages the power of large-language-models (LLMs) to deliver unparalleled choice and capabilities. The company has seen rapid growth over the past 12 months, scaling its number of customers, revenue, and operational headcount to meet growing demand across multiple geographies. Aviz has witnessed a 250% growth in revenues with over 30 global customer engagements of various size.

Over the past three years, SONiC has emerged as a multibillion entity in the cloud and data center networking space, expected to reach $8B by 2027, according to research from communications industry analyst firm 650 Group.

“We are delighted to close this latest funding round that includes Accton, Cisco Investments, Moment Ventures, and Wistron. Our vision of delivering open, cloud & AI enabled networks for all enterprises and telecoms has rapidly taken shape as we partner with customers and our vendor ecosystem,” said Vishal Shukla, Co-Founder and CEO for Aviz. “Aviz continues to focus on supporting and leveraging community SONiC, and adding compelling innovations that enhance quality, drive down costs and accelerate time to deployment of open, cloud networks.”

“Accton is proud to be participating in this investment round with other global network leaders as it underscores our commitment to innovation in open networking. Aviz Networks has been extremely successful this year in the multi-billion dollar open network market, where SONiC plays a significant role. Accton is always pleased to collaborate with those that share our collective vision of employing AI and other cutting-edge technologies to meet the networking needs of enterprises and telcos,” said Jun Shi, CEO and President of Accton Group.

“Cisco is committed to accelerating innovation in networking to deliver comprehensive solutions to our customers,” says Aleem Rizvon, Vice President of Cisco Investments. “By investing in innovative startups, like Aviz, we are demonstrating our commitment to our partners and customers who value the open-source community.”

“Wistron is excited to see the multiple innovations and execution coming from Aviz as an early-stage company extending its reach to address the challenges of enterprise data center and cloud networks,” said William Lin, President of Enterprise & Networking B.G., Wistron Corporation. “Wistron is participating in this investment round so that our companies can work closely together to deliver the right solutions and substantial cost savings to enterprises as driven with robust SONiC edge deployments.”

About Aviz

Aviz Networks is a leading provider of solutions for Open, Cloud, and AI first networks. Aviz delivers switch platform agnostic, easy-to-use applications and APIs for network observability, orchestration, and assurance. Aviz also provides disaggregated support for multi-vendor SONiC deployments in data centers & edge networks. Aviz is on a mission to make SONiC a ubiquitous, accessible, and intelligent NOS for every stakeholder.

Learn more about Aviz at


View source version on




Aviz Networks Contact:

ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology

 IRVINE, Calif. - Wednesday, 29. November 2023 AETOSWire

(BUSINESS WIRE)--ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a history of heart failure, a series of failed surgical by-pass grafts and severe mitral regurgitation (MR 4+), was successfully treated with the Palmetto System.

The next generation TMVR procedure was performed using ReValve’s Palmetto System on October 11, 2023, at the Punta Pacifica Hospital, Panama City, Panama by Interventional Cardiologists Dr. Charles Davidson (Medical Director, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital) and Dr. Temistocles Diaz (Chief of Interventional Cardiology at Punta Pacifica Hospital), along with Cardiovascular Surgeon Dr. Douglas Boyd, (Professor of Surgery, Vice Chair, Department of Cardiovascular Sciences, East Carolina University) and Echocardiographer Dr. Edris Aman (Assistant Clinical Professor of Cardiovascular Medicine at the University of California, Davis Medical Center). The procedure was successfully completed in under an hour reducing the patient’s MR to trace. At 30 days, the patient continues to do well with zero MR and preserved ventricular function.

ReValve’s technology is designed to replace the Mitral Valve while also preserving the heart’s natural basal left ventricular function. “Our approach to TMVR is unique in that we work with the natural movement of the heart, as opposed to first-generation technologies which require the heart to work around a stiff implant. Our flexibility and four-point securement system provide a patent LVOT and maintains left ventricular function throughout recovery,” said Julie Logan Sands, Founder and CEO ReValve Solutions. “Many of the issues of Neo-LVOT and LV dysfunction were not fully understood nor anticipated in first generation technologies. ReValve’s first-of-its-kind TMVR is thoughtfully designed to expand the treatable population of patients suffering from Mitral Valve Disease,” added Sands.

“The procedure is straightforward, while the valve and delivery system performed as designed. Leaflet securement along with the low-profile valve frame helps to avoid LVOT obstruction that has been a significant limitation of several TMVR technologies. This first in human experience is very encouraging to expand transcatheter mitral valve replacement to a larger population,” said Dr. Davidson.

“The ReValve system is a promising technology. The immediate patient recovery is quite remarkable with preservation of the left ventricular function. The next morning the patient stated he was ready to sing again, we could not have had a better outcome,” said Dr. Diaz.

About ReValve Solutions

The Palmetto System is a complete mitral valve replacement system delivered via transfemoral-transseptal approach. The system is designed to avoid any disturbance to the left-ventricular outflow tract while preserving the basal left ventricular function and if needed, will allow for future replacement through a dedicated product line. Preserving options for the physician and patient is an essential part of the long-term solution to structure heart treatment. ReValve is an investigational device only and not available for sale.

ReValve Solutions, Inc. ( is based in Irvine, CA with the mission of delivering innovative solutions to structural heart disease through catheter-based procedures which allow for long-term treatment options. For more information visit


View source version on



Julie Logan Sands,

Thursday, November 30, 2023

MSCI Appoints Jana Haines as Head of Index

 (BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of mission-critical decision support tools and services for the global investment community, today announced that Jana Haines has joined the firm as Head of Index and as a member of MSCI’s Executive Committee.

Based in New York, Ms. Haines will be responsible for the strategic development and execution of MSCI’s global Index product line. She will partner with senior leaders across the firm to manage the Index product development process. Ms. Haines will aim to drive innovation across index categories, including market cap, sustainability, climate, factors, thematics and asset classes, such as fixed income and private assets.

"As a longtime business leader, Jana has a proven track record of strategic thinking and a unique understanding of the value of MSCI’s indexes to investors,” said Baer Pettit, President and Chief Operating Officer of MSCI. “Jana’s extensive expertise in the global financial industry will be critical to MSCI building an even deeper understanding of our clients’ evolving needs for indexes that help them build better portfolios and develop investable financial products.”

Ms. Haines held a variety of senior leadership roles at MSCI from 2006 to 2021. Most recently, she served as Head of Index Product for Americas and EMEA, and Global Head of Fixed Income Indexes. Earlier in her tenure at MSCI, she held various roles within the Client Coverage team.

Since 2021, Ms. Haines was the Chief Strategy Officer of ARK Investments, where she worked alongside CEO Cathie Wood. She was instrumental in ARK’s transition to a scalable business and expanding the firm’s global partnerships.

Before she joined MSCI in 2006, Ms. Haines garnered diverse experience in financial markets at HypoVereinsbank and Richie Capital. She also co-founded the Private Equity Group in Prague. Ms. Haines holds an MBA from the University of Chicago Booth School of Business.

“I am deeply excited to rejoin MSCI at this time of tremendous innovation and expansion of the investment community’s needs and uses for indexes,” said Ms. Haines. “From diversification to decarbonization goals, investors need differentiated, high-quality data and timely insights to confidently drive outcomes in an ever-changing world. MSCI is uniquely well-placed to serve these needs of investors through the creation and management of best-in-class indexes, and I am looking forward to leading the next phase of innovation at MSCI to help our clients make better investment decisions.”

About MSCI Inc.

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data, and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process. To learn more, please visit

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or performance and involve risks that may cause actual results or performance differ materially and you should not place undue reliance on them. Risks that could affect results or performance are in MSCI’s Annual Report on Form 10-K for the most recent fiscal year ended on December 31 that is filed with the SEC. MSCI does not undertake to update any forward-looking statements. No information herein constitutes investment advice or should be relied on as such. MSCI grants no right or license to use its products or services without an appropriate license. MSCI MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OTHERWISE WITH RESPECT TO THE INFORMATION HEREIN AND DISCLAIMS ALL LIABILITY TO THE MAXIMUM EXTENT PERMITTED BY LAW.


View source version on




Media Inquiries

Melanie Blanco +1 212 981 1049

Konstantinos Makrygiannis +44 (0) 7768 930056

Tina Tan +852 2844 9320

MSCI Global Client Services

EMEA Client Service + 44 20 7618.2222

Americas Client Service +1 888 588 4567 (toll free)

Asia Pacific Client Service + 852 2844 9333

Rimini ONE™ Helps MYOB Achieve System Reliability and Operational Efficiency

 Australian SaaS provider selects Rimini Street’s end-to-end IT support and managed services to streamline part of its ecosystem and improve talent retention


(BUSINESS WIRE)--Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced MYOB, a leading SaaS provider based in Australia, has selected Rimini ONE™ to streamline and enhance the support of one of its core platforms. The decision allows MYOB’s internal development team to focus on delivering more strategic outcomes for the company.

MYOB’s Quest for a Strategic Software Support and Managed Services Partner

MYOB is a business management platform that brings together key workflows for small and medium sized enterprises, from finance and supply chain to employee and project management. Since the early nineties, MYOB has been part of the fabric of doing business in Australia and New Zealand, helping businesses start, survive, and succeed.

The company’s ecosystem relies on CRM and ERP solutions that have been fundamental to its operations for decades. MYOB conducted an extensive market scan to find a partner to support these solutions and that could truly comprehend its unique needs.

“Rimini Street was the clear choice for us. They weren’t just looking to sell us what they’ve got off the shelf. The team really wanted to understand our systems, processes, and our problems to ensure a good fit,” said Catherine Quinn, platform delivery lead at MYOB.

Stefan Vargheese, engineering manager at MYOB, echoed her sentiments: “It was not a one-size-fits-all solution. Rimini Street really took our needs and business goals into consideration. Having managed services and issue resolution in a seamless, end-to-end solution, without multiple vendors or multiple tickets, was a no-brainer for us.”

MYOB Improves Efficiency and Talent Retention with Rimini ONETM

MYOB chose Rimini ONE, an end-to-end outsourcing solution for enterprise applications, databases, and technology software, to manage its Siebel platform. This increases efficiencies, ensures seamless operations, fosters collaborative issue resolution, and enables expertly tailored solutions.

Ensuring Uninterrupted Operations

Business continuity and system uptime are paramount for MYOB as their agents and customers require uninterrupted access to their software. “Rimini Street gives us peace of mind that our core applications will be available whenever they are needed,” added Quinn.

Cultivating Collaborative Issue Resolution

Rimini Street takes a proactive approach pinpointing and remedying the root causes of issues, working closely with MYOB engineers for faster resolution.

Delivering Expertise and Custom Solutions

The Rimini Street approach provides MYOB with expertise and skillsets to tackle any scenario. “They throw themselves in, understand the problem and work out the best solution. There have been a few things that they haven’t seen before, but that absolutely hasn’t fazed them at all,” explained Quinn.

Switching to Rimini ONE opened more opportunities for MYOB and empowered the team to work more efficiently and more flexibly, as well as save costs. “Rimini ONE provides a truly one-of-a-kind solution that’s a must for modern-day organizations,” said Vargheese.

Rimini ONE eliminated the need for the team to spend time on after-hours support, resulting in increased productivity, improved work-life balance, and enhanced talent retention. Vargheese noted, “The team is more productive when they’re working on strategic, future-focused projects. The partnership is definitely paying off dividends.”

“We are pleased to work with MYOB to help them optimize their IT ecosystem and empower their development team to focus on strategic innovation,” said Craig Mackereth, executive vice president of global service delivery at Rimini Street. “This partnership underscores Rimini Street’s commitment to providing tailored, end-to-end support solutions that meet the unique needs of our clients and enable them to achieve their business objectives with confidence.”

Access additional details on how Rimini Street enables MYOB here.

Explore the full Rimini Street portfolio of ultra-responsive, trusted and proven support, managed services, security, integration, observability, professional services and Rimini ONE™ end-to-end outsourcing solutions for SAP, Oracle and Salesforce applications to support competitive advantage, profitability and growth.

About Rimini Street, Inc.

Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software and a Salesforce and AWS partner. The Company has operations globally and offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize enterprise application, database, and technology software, and enables clients to achieve better business outcomes, significantly reduce costs and reallocate resources for innovation. To date, over 5,300 Fortune 500, Fortune Global 100, midmarket, public sector, and other organizations from a broad range of industries have relied on Rimini Street as their trusted enterprise software solutions provider. To learn more, please visit, and connect with Rimini Street on Twitter, Instagram, Facebook and LinkedIn. (IR-RMNI)

Forward-Looking Statements

Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “anticipate,” “believe,” “continue,” “could,” “currently,” “estimate,” “expect,” “future,” “intend,” “may,” “might,” “outlook,” “plan,” “possible,” “potential,” “predict,” “project,” “seem,” “seek,” “should,” “will,” “would” or other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, adverse developments in and costs associated with defending pending litigation or any new litigation, including the disposition of pending motions to appeal and any new claims; additional expenses to be incurred in order to comply with injunctions against certain of our business practices and the impact on future period revenue and costs; changes in the business environment in which Rimini Street operates, including the impact of any recessionary economic trends and changes in foreign exchange rates, as well as general financial, economic, regulatory and political conditions affecting the industry in which we operate and the industries in which our clients operate; the evolution of the enterprise software management and support landscape and our ability to attract and retain clients and further penetrate our client base; significant competition in the software support services industry; customer adoption of our expanded portfolio of products and services and products and services we expect to introduce; our ability to sustain or achieve revenue growth or profitability, manage our cost of revenue and accurately forecast revenue; estimates of our total addressable market and expectations of client savings relative to use of other providers; variability of timing in our sales cycle; risks relating to retention rates, including our ability to accurately predict retention rates; the loss of one or more members of our management team; our ability to attract and retain qualified employees and key personnel; challenges of managing growth profitably; our need and ability to raise additional equity or debt financing on favorable terms and our ability to generate cash flows from operations to help fund increased investment in our growth; the impact of environmental, social and governance (ESG) matters; risks associated with global operations; our ability to prevent unauthorized access to our information technology systems and other cybersecurity threats, protect the confidential information of our employees and clients and comply with privacy regulations; our ability to maintain an effective system of internal control over financial reporting; our ability to maintain, protect and enhance our brand and intellectual property; changes in laws and regulations, including changes in tax laws or unfavorable outcomes of tax positions we take, or a failure by us to establish adequate tax reserves; our credit facility’s ongoing debt service obligations and financial and operational covenants on our business and related interest rate risk, including uncertainty from the transition to SOFR or other interest rate benchmarks; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the amount and timing of repurchases, if any, under our stock repurchase program and our ability to enhance stockholder value through such program; uncertainty as to the long-term value of Rimini Street’s equity securities; catastrophic events that disrupt our business or that of our clients; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on November 1, 2023, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.

© 2023 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.


View source version on



Janet Ravin

VP, Global Communications

Rimini Street, Inc.

+1 702 285-3532